Originally published In Press as doi:10.1074/jbc.M001118200 on April 18, 2000
J. Biol. Chem., Vol. 275, Issue 25, 18871-18878, June 23, 2000
Isolation and Characterization of Various Complexes of the
Minichromosome Maintenance Proteins of Schizosaccharomyces
pombe*
Joon-Kyu
Lee and
Jerard
Hurwitz
From the Graduate Program in Molecular Biology, Memorial
Sloan-Kettering Cancer Center, New York, New York 10021
Received for publication, February 9, 2000, and in revised form, March 30, 2000
 |
ABSTRACT |
Minichromosome maintenance (Mcm) proteins 2-7
are highly conserved in eukaryotes and play an essential role in DNA
replication. Here, we describe the reconstitution of the various
complexes of the Mcm proteins of Schizosaccharomyces pombe
using the baculovirus expression system. The simultaneous expression of
all six of the Mcm proteins, as well as different combinations of these
proteins, yielded several stable complexes that included the
heterohexamer of Mcm2/3/4/5/6/7, the Mcm2/4/6/7 heterotetramer, the
dimer of the Mcm4/6/7 heterotrimer, and the Mcm3/5 heterodimer. The
purification and characterization of the biochemical properties of
these complexes showed that only the dimeric complex of the Mcm4/6/7
heterotrimer possessed single stranded DNA-dependent
ATPase, ATP-dependent single stranded DNA binding, and 3'
to 5' DNA helicase activities. Consistent with these results, the
interaction of either Mcm2 or Mcm3/5 with the Mcm4/6/7 complex resulted
in the disassembly of the dimeric complex of Mcm4/6/7 and the loss of
DNA helicase activity. These results suggest that the Mcm4/6/7 complex
is a catalytic core of the Mcm complex and that Mcm2 and Mcm3/5 may be
involved in the regulation of the activity of this complex.
 |
INTRODUCTION |
Minichromosome maintenance
(MCM)1 genes were
initially identified as genes that were required for the maintenance of
minichromosomes in the yeast Saccharomyces cerevisiae (1).
Among these genes, six MCM genes, consisting of MCM2,
MCM3, MCM4, MCM5, MCM6, and MCM7, encode a family of
proteins that are structurally related (2) and highly conserved in all
eukaryotes (3). All six of these genes are essential for DNA
replication (4-6). Genetic and physical interactions between these
gene products and proteins involved in the initiation of DNA
replication, such as the origin recognition complex (ORC), Cdc6, Cdc45,
and Cdc7/Dbf4 kinase, have been reported in S. cerevisiae
(7-16). The Mcm2-7 proteins were shown to be components of the
pre-replicative complex and the assembly of these proteins onto
replication origins is required for the initiation of DNA replication
(9, 17-21). A protein complex containing all six Mcm proteins was
identified and purified as a factor required for one round of DNA
replication in the Xenopus system (called licensing factor)
(22-24). The formation of a heterohexameric complex containing all six
Mcm proteins, as well as the formation of subcomplexes such as
Mcm2/4/6/7, Mcm4/6/7, or Mcm3/5, have been also identified in extracts
prepared from various organisms, including human (25-30),
Xenopus (24, 31, 32), Drosophila (33), S. cerevisiae (34, 35), and Schizosaccharomyces pombe (36-38). Although the role of these complexes in DNA replication is
not fully understood, in vitro studies showed that the
dimeric complex of the human and mouse Mcm4/6/7, as well as the
dodecameric complex of the single archaeon Methanobacterium
thermoautotrophicum (mth) Mcm protein, contained DNA helicase,
single stranded (ss) DNA binding, and DNA-dependent ATPase
activities (27, 39, 40). It has been also demonstrated that Mcm2
interacted with the Mcm4/6/7 complex and inhibited the helicase
activity of this complex (41). These biochemical properties, taken
together with the genetic data obtained from yeast, suggest that the
Mcm proteins may play a role as the replicative helicase in eukaryotes,
similar to that of the bacterial DnaB protein or the large T antigen (T Ag) of simian virus 40 (SV40) (42-44).
In this study, various complexes of the Mcm proteins of S. pombe containing different Mcm subunits were reconstituted and purified to near homogeneity using the baculovirus expression system.
The characterization of the biochemical properties of these complexes
showed that only the Mcm4/6/7 complex contained activities similar to
the human and mouse Mcm4/6/7 complex and the mthMcm protein (multimer
complex). We also describe the direct interaction between the S. pombe Mcm4/6/7 complex and Mcm2 or the Mcm3/5 heterodimer. Such
interactions resulted in the alteration of the dimeric structure of the
Mcm4/6/7 complex and the loss of DNA helicase activity.
 |
MATERIALS AND METHODS |
Reagents--
Labeled and unlabeled dNTPs and rNTPs were
obtained from Amersham Pharmacia Biotech. Single stranded M13mp18 and
x174 DNAs and pUC19 plasmid DNA were from New England Biolabs.
Anti-FLAG M2 Ab-agarose and FLAG peptide were from Sigma.
Escherichia coli ssDNA-binding protein (SSB) was from
Amersham Pharmacia Biotech, and recombinant S. pombe SSB was
purified from E. coli cells as described previously (45).
Oligonucleotides were synthesized by Integrated DNA Technologies
(Coralville, IA), and rabbit polyclonal antibodies were generated by
Cocalico Biologicals (Reamstown, PA).
Cloning of MCM Genes into Baculovirus Transfer Vectors and
Preparation of Recombinant Viruses--
DNAs containing
spmcm2+ (nda1+,
cdc19+) (pREP1-nda1), spmcm5+
(nda4+) (pREP1-nda4),
spmcm6+ (mis5+) (p268-1)
(kindly provided by Dr. M. Yanagida, Kyoto University, Japan) (46, 47),
and spmcm4+ (pREP3x-cdc21, kindly provided by
Dr. S. E. Kearsey, University of Oxford, United Kingdom) (48),
were used for the preparation of baculovirus transfer vectors for Mcm2,
5, 6, and 4, respectively. The DNA linker containing the
BssHII (5'-TATTGGCGCGCCAA-3') site was added to the
NdeI site of pREP1-nda1 or pREP1-nda4, and
BssHII-SmaI fragments containing the
spmcm2+ or the spmcm5+
gene were subcloned into the BssHII and StuI
sites of pFastBac1 plasmid (Life Technologies, Inc.). To remove the
intron from the spmcm5+ gene, the
EcoRI-MluI fragment was replaced with the
cDNA fragment obtained by PCR. The constructs encoding the
spmcm2+ or spmcm5+ genes
that contain six histidines and FLAG (His6/FLAG) tags at the N terminus were made as above except for the use of
BssHII linker encoding the His6/FLAG epitope
(5'-TAGCGCGCCACCATGCATCACCATCACCATCACGATTATAAAGATGACGATGACAAGGG-3' and 5'-TACCCTTGTCATCGTCATCTTTATAATCGTGATGGTGATGGTGATGCATGGTGGCGCGC-3'). The construct containing spmcm4+
(cdc21+) was made by subcloning the
XhoI-SacI fragment of pREP3X-cdc21 into
SalI and SacI sites of the pFastBac1 plasmid. The
cDNA fragment encoding spMcm6 (Mis5) was amplified by PCR using Pfu
polymerase (Stratagene), p268-1 plasmid DNA as a template, and
oligonucleotides 5'-GTCAGCGCGCACTACACTTGAAGATGTC-3' and
5'-GTTTCTGCGGTATGCAGTG-3' as primers. After digestion with
BssHII, this DNA fragment was subcloned into the
BssHII and StuI sites of pFastBac1 plasmid.
The spmcm3+ and spmcm7+
genes were obtained by PCR amplification from an S. pombe
cDNA library. Oligonucleotides
5'-GTCAGCGCGCTGAAAAGCATGGCACTTCC-3' and
5'-CAGAAAAGTAGTTTGACGTC-3' were used for the amplification of
spmcm7+ gene and oligonucleotides
5'-GTCAGCGCGCAGCAAAATGACTGAGCTGTTAGCAG-3' and
5'-GTGAACCAGGAACCACGATATG-3' were used for the amplification of the
spmcm3+ gene. The PCR products were digested
with BssHII and subcloned into the BssHII and
StuI sites of pFastBacI plasmid. To construct the
spmcm7+ gene containing the
FLAG/His6-tag at the C terminus, the PCR product was
subcloned into the EcoRV site of pBluescript II KS(
) and
the linker containing the FLAG/His6 coding sequences
(5'-CCGGATTTACATATGGAGAATGGTGATTATAAAGATGACGATGACAAGCATCACCATCACCATCACTAA-3' and
5'-CCGGTTAGTGATGGTGATGGTGATGCTTGTCATCGTCATCTTTATAATCACCATTCTCCATATGTAAAT-3') was inserted into the BspEI site, and the
BssHII-SmaI fragment containing the modified
spmcm7+ gene was transferred into the pFastBac1
plasmid. The nucleotide sequences of the PCR products and linker
regions were confirmed by DNA sequencing. All recombinant viruses were
produced according to the manufacturer's protocols (BAC-TO-BAC
Baculovirus Expression Systems, Life Technologies, Inc.).
Expression of Mcm Complexes in Insect Cells--
Sf9
insect cells were cultured at 27 °C in Grace's medium supplemented
with 10% fetal bovine serum. For the expression of various Mcm
complexes, Sf9 cells (2 × 106 cells/ml) were
co-infected with various combinations of recombinant baculoviruses
expressing each Mcm subunit at a multiplicity of infection of 5, and
incubated at 27 °C for 48 h. To facilitate the purification of
the Mcm2/3/4/5/6/7 and Mcm3/5 complexes, baculovirus containing the
mcm5+ gene that was tagged with
His6/FLAG at its N terminus was used with other recombinant
viruses harboring wild-type mcm genes. For the purification
of the Mcm4/6/7 and Mcm2/4/6/7 complexes, recombinant viruses carrying
either the C-terminal FLAG/His6-tagged mcm7+ gene or N-terminal
His6/FLAG-tagged mcm2+ were used, respectively.
Purification of Various Mcm Complexes--
The recombinant Mcm
complexes in infected Sf9 cell lysates were purified by the
consecutive steps involving nickel-agarose affinity chromatography,
anti-FLAG M2 Ab-agarose affinity chromatography, and glycerol gradient
sedimentation. Sf9 cells (2 × 106 cells/ml, 1 liter) were infected simultaneously with various combinations of
recombinant viruses and incubated at 27 °C for 48 h to produce
the Mcm2/3/4/5/6/7, Mcm4/6/7, Mcm2/4/6/7, and Mcm3/5 complexes. The
cells were harvested, washed once with 100 ml of ice-cold
phosphate-buffered saline, and then resuspended in 30 ml of buffer A
(20 mM Tris-HCl, pH 7.5, 0.3 M sodium
glutamate, 2 mM magnesium acetate, 0.05% Nonidet P-40,
10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 10 µg/ml pepstatin A, 10 µg/ml aprotinin)
containing 10 mM imidazole and 0.25% Triton X-100. After
incubation on ice for 20 min, the supernatant solutions were collected
by centrifugation at 35,000 × g at 4 °C for 30 min
and then mixed with 1.5 ml of Ni2+-agarose beads
(Invitrogen) pre-equilibrated with buffer A. The mixtures were
incubated at 4 °C for 2 h on a rocking platform. The beads were
collected, washed four times with 40 ml of buffer A containing 10 mM imidazole, and packed in a column (0.7 × 4 cm).
Bound protein was eluted five times each with an equal bead volume of
buffer A containing 150 mM imidazole. The eluted fraction was mixed with anti-FLAG M2 Ab-agarose beads (Sigma) equilibrated with
buffer A (about 0.5-ml beads/mg of protein) and incubated at 4 °C
for 1 h on a rocking platform. After washing four times with
10 bead volumes of buffer A, bound protein was eluted three times by
incubation at 4 °C for 30 min with an equal bead volume of buffer A
containing 0.2 mg/ml of the FLAG peptide. From 2 × 109 infected Sf9 cells, this step yielded 0.43 mg of
Mcm2/3/4/5/6/7, 0.14 mg of Mcm2/4/6/7, 1.8 mg of Mcm4/6/7, 0.48 mg of
Mcm3/5, and 2.5 mg of Mcm2. A portion of each of the anti-FLAG M2 Ab
affinity column eluates was further purified by glycerol gradient
centrifugation (as described below). During the purification, the
presence of various Mcm complexes was monitored by Western blotting or
by Coomassie Brilliant Blue staining of SDS-PAGE gels. Protein
concentrations were determined by the Bradford method (Bio-Rad) with
bovine serum albumin (BSA) as the standard.
Glycerol Gradient Centrifugation--
A portion of the fraction
isolated after anti-FLAG Ab affinity column chromatography (0.2 ml) was
applied to a 5-ml 15-35% glycerol gradient in buffer B (20 mM Hepes-NaOH, pH 7.5, 200 mM sodium glutamate,
2 mM magnesium acetate, 1 mM DTT, 0.05%
Nonidet P-40). After centrifugation at 45,000 rpm for 13 h in a
Beckmam SW 50.1 rotor at 4 °C, fractions (250 µl) were collected
from the bottom of the tube. The distribution of the Mcm protein was determined after SDS-8% PAGE and staining with Coomassie Brilliant Blue (R-250).
Gel-filtration Analysis--
A portion of the purified fraction
(anti-FLAG Ab affinity column eluate, 20-40 µg) was applied to a
Superdex-200 gel filtration column (HR10/30, Amersham Pharmacia
Biotech) equilibrated with buffer C (20 mM Hepes-NaOH, pH
7.5, 2 mM magnesium acetate, 1 mM DTT, 0.05%
Nonidet P-40, 5% glycerol) containing 50 mM sodium acetate. Fractions (250 µl) were collected and analyzed for the Mcm
complex by SDS-8% PAGE and staining with Coomassie Brilliant Blue
(R-250).
DNA Helicase Assay--
For the preparation of substrates used
for the assay of helicase activity, a 17-mer oligonucleotide
(5'-GTTTTCCAGTCACGAC-3',
40 sequencing primer for M13) was
synthesized and annealed to M13mp18 ssDNA. After labeling of the 3'-end
of the annealed 17-mer DNA with [
-32P]dGTP and the
Klenow fragment, the labeled 18-mer/M13mp18 ssDNA was purified by
Sephadex G-50 column chromatography. The substrates used to determine
the direction of translocation of the helicase were prepared as
follows. For the preparation of the 3'-tailed substrate, a 36-mer
oligonucleotide (5'-GACTCTAGAGGATCCCCGGGTACCGAGCTCGAATTC-3') was
synthesized, labeled at its 5'-end with [
-32P]ATP and
T4 polynucleotide kinase, and annealed to M13mp18 ssDNA. After
digestion of this annealed DNA with SmaI, DNA was purified by Sephadex G-50 column chromatography. For the preparation of the
5'-tailed substrate, a 36-mer oligonucleotide was annealed to M13mp18
ssDNA and labeled at its 3'-end with [
-32P]dGTP and
Klenow fragment. This DNA was digested with SmaI and purified by Sephadex G-50 column chromatography. To determine the
maximal length of duplex DNA displaced by the Mcm4/6/7 helicase, a
substrate containing longer duplex regions was prepared by elongating singly primed M13mp18 ssDNA using Sequenase (U. S. Biochemical Corp.). For this purpose, the M13 forward sequencing primer was annealed to M13mp18 ssDNA and the 3' end of this oligomer was labeled
with [
-32P]dGTP and [
-32P]dTTP in the
presence of Sequenase, and then elongated in the presence of ddCTP and
all four dNTPs according to the manufacturer's protocol. The DNA
product was purified by Sephadex G-50 column chromatography. The
resulting substrate (25,000 cpm/fmol) contained duplex regions that
varied in length between 22 and 600 base pairs.
DNA helicase activity was measured in reaction mixtures (15 µl)
containing 25 mM Hepes-NaOH (pH 7.5), 25 mM
sodium acetate, 12.5 mM magnesium acetate, 4 mM
ATP, 1 mM DTT, 0.1 mg/ml BSA, 5 fmol of
32P-labeled substrate (4,000 cpm/fmol), and enzyme
fraction. After incubation at 32 °C for 1 h, 4 µl of 5 × loading buffer (100 mM EDTA, 0.5% SDS, 0.1% xylene
cyanol, 0.1% bromphenol blue, and 25% glycerol) was added, and 7-µl
aliquots were loaded onto a 15% polyacrylamide gel containing 0.1%
SDS in 1 × TBE (90 mM Tris, 90 mM boric
acid, 1 mM EDTA) and electrophoresed for 1 h at 150 V.
Gel Mobility Shift Assay--
The 41-mer oligonucleotide
(5'-AATCATAGATAGTATCTCCGTGCAAGATAATCACGAGTATC-3') or
oligo(dT)50 was labeled at the 5'-end with 32P
by using [
-32P]ATP and T4 polynucleotide kinase and
used as the substrate for gel mobility shift assays. Enzyme fractions
were incubated at 25 °C for 20 min in reaction mixtures (15 µl)
containing 25 mM Hepes-NaOH (pH 7.5), 50 mM
sodium acetate, 10 mM magnesium acetate, 1 mM
DTT, 0.1 mg/ml BSA, and 20 fmol of 5'-labeled 41-mer ssDNA (4,000 cpm/fmol), in the presence or absence of ATP or ATP analogues. After
addition of 2 µl of 50% glycerol, aliquots of reaction mixtures were
electrophoresed for 3 h at 120 V through a 4.5% polyacrylamide gel containing 6 mM magnesium acetate and 5% glycerol in
0.5 × TBE at 4 °C.
Nitrocellulose Filter Binding Assay--
Nitrocellulose filter
binding assays were carried out in reaction mixtures (15 µl)
containing 25 mM Hepes-NaOH (pH 7.5), 50 mM
sodium acetate, 10 mM magnesium acetate, 1 mM
DTT, 0.1 mg/ml BSA, 20 fmol of 5'-labeled 41-mer ssDNA (4,000 cpm/fmol), and enzyme fractions in the presence or absence of ATP or
ATP analogues. After incubation at 25 °C for 20 min, mixtures were
filtered through an alkaline-washed nitrocellulose filter (Millipore,
HA 0.45 µm) (49), and then washed with buffer containing 25 mM Hepes-NaOH (pH 7.5), 50 mM sodium acetate,
10 mM magnesium acetate, and 1 mM DTT. The
radioactivity adsorbed to the filter was determined by liquid
scintillation counting.
ATPase Assay--
ATPase activity was measured in reaction
mixtures (15 µl) containing 25 mM Hepes-NaOH (pH 7.5), 50 mM sodium acetate, 5 mM magnesium acetate, 1 mM DTT, 0.1 mg/ml BSA, 1.5 nmol of
[
-32P]ATP (1.5 × 104 cpm/pmol),
indicated amounts of polynucleotide, and the enzyme fraction. After
incubation at 30 °C for 1 h, aliquots (1 µl) were spotted
onto a polyethyleneimine-cellulose thin-layer plate, and ATP and
Pi were separated by chromatography in 1 M
formic acid, 0.5 M LiCl. The extent of ATP hydrolysis was
quantitated by PhosphorImager (Fuji) analysis. The 25-mer
oligonucleotide used in this study contained the sequence
5'-GCAAGCACATCACCTTGAATGCCAC-3'.
Preparation of Antibodies against Mcm Proteins and
Immunoprecipitation Studies--
For the preparation of polyclonal
antibodies against the different Mcm proteins, regions of the
mcm genes (encoding amino acids 22 to 460 for
mcm2, 3 to 399 for mcm6, 4 to 371 for
mcm4, 3 to 313 for mcm3, 520 to 758 for
mcm7, and 77 to 350 for mcm5) were cloned into
the BamHI site of pET28-a (Novagen), expressed, and purified
from E. coli BL21(DE3) cells by Ni2+-agarose
chromatography using denaturing conditions as described by the
manufacturer's protocols (Novagen). After SDS-10% PAGE, protein bands
were excised from the gel and used for immunization of rabbits.
In order to determine the interactions between the different Mcm
complexes, polyclonal antibodies against Mcm4 or Mcm2 (0.5 µl of
serum) were added to various mixtures of Mcm complexes in buffer C (150 µl) containing 0.1 M sodium glutamate and 0.1 mg/ml BSA.
After incubation at 4 °C for 30 min, protein A-agarose beads (15 µl) were added and the mixture was incubated for an additional 30 min. The beads were washed three times with 1 ml of buffer C containing
0.1 M sodium glutamate and 0.1 mg/ml BSA and then once with
buffer C containing 0.1 M sodium glutamate. Proteins bound
to the beads were then analyzed by SDS-8% PAGE followed by staining
with silver.
 |
RESULTS |
Reconstitution and Purification of Various Recombinant S. pombe Mcm
Protein Complexes--
In order to determine the biochemical
properties of S. pombe Mcm protein complexes containing
various subunits, Mcm complexes were reconstituted using the
baculovirus expression system. To facilitate the purification of
proteins and complexes, a His6/FLAG-tag was added to the N
terminus of the Mcm2 or Mcm5 proteins, or to the C terminus of the Mcm7
protein. The addition of the His6/FLAG-tag at the N
terminus of Mcm2 or Mcm5 proteins did not appear to affect their
biological activity. The expression of these tagged proteins under the
control of nmt1 promoter in the presence of thiamine complemented the cold-sensitive phenotypes of nda1-376
(mcm2) or nda4-108 (mcm5) mutant
strain. After co-infection of baculoviruses encoding each of the Mcm
proteins in various combinations, we obtained stable complexes that
included Mcm2/3/4/5/6/7, Mcm2/4/6/7, Mcm4/6/7, Mcm3/5, as well as Mcm2.
These proteins were purified to near homogeneity by
Ni2+-agarose chromatography, anti-FLAG M2 Ab-agarose
chromatography, and glycerol gradient centrifugation as described under
"Materials and Methods." All of the purified Mcm complexes were
more than 80% homogeneous after the anti-FLAG Ab affinity-peptide
elution step.
The purity and stoichiometry of the various subunits present in the
different complexes were examined following glycerol gradient sedimentation followed by SDS-PAGE and Coomassie Blue staining. The
peak glycerol gradient fractions included each protein expected in the
complex (Fig. 1, A-D, and Fig.
2A) and contained subunits that stained with similar intensity. This suggests that the subunits that constituted each complex were present in stoichiometric
amounts.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Glycerol gradient sedimentation analysis of
the different Mcm complexes isolated from baculovirus-infected
Sf9 cells. The Mcm complexes and Mcm2 protein preparations
isolated after anti-FLAG Ab affinity column chromatography as described
under "Materials and Methods" were loaded onto 5-ml 15-35%
glycerol gradients and centrifuged for 13 h at 45,000 rpm in a
Beckman SW50.1 rotor at 4 °C (Panel A, Mcm2/3/4/5/6/7;
B, Mcm2/4/6/7; C, Mcm3/5; D, Mcm2). After
collection of 20 fractions from the bottom of the tubes, aliquots (15 µl) of each fraction were subjected to SDS-10% PAGE analysis and
stained with Coomassie Blue. Arrows indicate the positions
of marker proteins that were run in a separate gradient. The marker
proteins used in these experiments were thyroglobulin (Thy,
19.0 S), catalase (Cat, 11.3 S), and bovine serum albumin
(4.3 S). Lanes M, molecular weight marker proteins;
LO, material loaded onto the glycerol gradient.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Glycerol gradient sedimentation analysis of
the Mcm4/6/7 complex. A, the purified Mcm4/6/7 complex
(200 µl, 80 µg of protein), isolated after anti-FLAG Ab affinity
column chromatography, was loaded onto a 5-ml 15-35% glycerol
gradient and centrifuged for 13 h at 45,000 rpm in a Beckman
SW50.1 rotor at 4 °C. After collection of 20 fractions from the
bottom of the gradient, aliquots (15 µl) of each fraction were
subjected to SDS-10% PAGE analysis and stained with Coomassie Blue.
B, distribution of DNA-dependent ATPase activity
in glycerol gradient fractions after sedimentation. The ATPase activity
assays were carried out in the presence of x174 ssDNA (450 ng) and
1-µl aliquots of each fraction. The numbers at the
bottom of the autoradiogram denote the amount of
32Pi released (in picomole) quantitated by
PhosphorImager analysis. C, distribution of DNA helicase
activity in glycerol gradient fractions. The assay for helicase
activity was carried out with 1.5-µl aliquots of each fraction using
5 fmol of M13mp18 ssDNA/18-mer (4,000 cpm/fmol) DNA as substrate as
described under "Materials and Methods." The numbers at
the bottom of the autoradiogram indicate the % of 18-mer
oligonucleotide displaced from the duplex. Lane B indicates
that the substrate was boiled prior to electrophoretic
separation.
|
|
The sedimentation coefficients (S) of these complexes, based on the
various markers shown in Fig. 1, A-D, and Fig.
2A, and the Stokes radii of the various preparations deduced
from the Superdex-200 gel filtration chromatography analysis (data not shown), are summarized in Table I. The
molecular masses (in kDa) of these complexes were calculated by the
method of Siegel and Monty (50), using the Stokes radii, the S values,
and assuming a partial specific volume of 0.725 ml/g for each
preparation. The deduced molecular masses of Mcm2/3/4/5/6/7,
Mcm2/4/6/7, Mcm3/5, and Mcm2 are in fair agreement with the molecular
weights calculated by summing the molecular weights of the protein
subunits of the complexes (Table I). These results suggest that
Mcm2/3/4/5/6/7, Mcm2/4/6/7, Mcm3/5, and Mcm2 were monomeric in
structure. In contrast, the molecular mass of the Mcm4/6/7 complex (542 kDa) was about 2-fold greater than the calculated molecular mass of the
heterotrimeric complex (284 kDa), suggesting that the structure of this
complex was a dimer of the heterotrimer.
In addition to the complexes described above, we also attempted to
isolate the Mcm3/4/5/6/7 and Mcm2/3/5 complexes. Coexpression of the
Mcm3, 4, 5, 6, and 7 proteins in Sf9 cells, followed by the
purification procedure described above, yielded a complex containing
stoichiometric amounts of each of these subunits after Ni2+-agarose chromatography. However, after further
purification, either Mcm4/6/7 or Mcm3/5 was isolated, depending upon
the Mcm subunit that contained the His6/FLAG-tag. These
observations suggest that the interaction between Mcm4/6/7 and Mcm3/5
complexes leads to a product that is relatively unstable. We also
attempted to coexpress and isolate the Mcm2/3/5 complex, but failed to
detect a stable interaction between Mcm2 and the Mcm3/5 complex.
The Mcm4/6/7 Complex Contains ATPase and DNA Helicase
Activities--
The biochemical activities associated with the
isolated complexes were examined. We determined whether these complexes
contained DNA-dependent ATPase, ssDNA binding, and DNA
helicase activities as described under "Materials and Methods."
Among the Mcm complexes, Mcm2/3/4/5/6/7, Mcm2/4/6/7, Mcm3/5, and Mcm2
were devoid of ssDNA binding and DNA helicase activities (data not
shown). We also failed to detect significant ATPase activity with
Mcm3/5 and Mcm2. Mcm2/3/4/5/6/7 and Mcm2/4/6/7 complexes possessed weak
ATPase activity. These complexes catalyzed the hydrolysis of 0.8 and 1.5 pmol of ATP/min/pmol of protein, respectively. The ATPase activity
associated with these complexes, however, was unaffected by DNA and the
possibility that this low activity was due to contaminants could not be
ruled out (data not shown). On the other hand, the Mcm4/6/7 complex
contained DNA-dependent ATPase, ssDNA binding, and DNA
helicase activities (Figs. 2-4). When the ATPase and the DNA helicase
activities present in the glycerol gradient fractions were determined,
both activities cosedimented with the heterotrimeric complex (Fig. 2,
A-C, peaking at fraction 8) suggesting that these are
intrinsic activities of this complex. The Mcm4/6/7 complex hydrolyzed
about 24 pmol of ATP/min/pmol of the dimer of the heterotrimer in the
presence of
X174 ssDNA under the assay conditions described in Fig.
2B.
Stimulation of the ATPase Activity of the Mcm4/6/7 Complex by
ssDNA--
The influence of various DNA preparations on the ATPase
activity of the glycerol gradient peak fraction (fraction 8) was
determined. As shown in Fig. 3, the
ATPase activity of the Mcm4/6/7 complex was stimulated about 3.5-fold
by
X174 ssDNA. Short ss oligonucleotides (25-mer or
oligo(dT)25) also stimulated the ATPase activity about 5-fold. In contrast, double stranded DNA (pUC19 plasmid DNA) did not
affect the ATPase activity of the complex. We also examined the effects
of other double stranded DNAs including DNAs containing S. pombe autonomous replicating sequences (ars 3002 and
ars 1), but failed to detect any stimulation (data not
shown).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
The influence of various DNAs on the ATPase
activity of the Mcm4/6/7 complex. The ATPase activity of Mcm4/6/7
complex (glycerol gradient peak fraction), as a function of protein
concentration, was determined in the absence or presence of the various
DNAs (30 ng/µl) as indicated. , reactions carried out in the
absence of DNA; , in the presence of pUC19 plasmid DNA; , x174
ssDNA; , oligo(dT)25; , 25-mer ssDNA. The assays were
as described under "Materials and Methods."
|
|
Mcm4/6/7 Complex Binding to ssDNA Is ATP-dependent--
We examined the interaction between the Mcm4/6/7 complex and
ssDNA. For this purpose, the Mcm4/6/7 complex (glycerol gradient peak
fraction, Fig. 2A) was incubated with a
32P-labeled 41-mer ssDNA in the presence or absence of ATP
or an ATP analogue, and the Mcm complexes bound to DNA were analyzed by
the gel mobility shift assay described under "Materials and Methods." As shown in Fig. 4, the
Mcm4/6/7 complex bound to ssDNA and this interaction required ATP.
Under the conditions used, the optimal concentration of ATP required
for this interaction was about 1 mM and higher
concentrations of ATP decreased the binding efficiency, presumably by
reducing the level of free Mg2+ ions. In support of this
notion, when the Mg2+ ion concentration was increased to 15 mM (in contrast to the 10 mM Mg2+
ion concentration used in the experiment described in Fig. 4), no
inhibition of binding was observed up to 5 mM ATP (data not presented). The non-hydrolyzable ATP analogue, ATP
S, also supported the binding of the Mcm4/6/7 complex to ssDNA, suggesting that this
interaction does not require ATP hydrolysis. These results were also
confirmed using a nitrocellulose filter binding assay (data not shown).
To rule out the possibility that these binding properties were caused
by the secondary structures present in the ssDNA, these experiments
were repeated with 32P-labeled oligo(dT)50 as
substrate. Results identical to those described with the
32P-labeled 41-mer ssDNA were obtained (data not
presented).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Single stranded DNA binding activity of the
Mcm4/6/7 complex. Indicated amounts of Mcm4/6/7 complex (glycerol
gradient peak fraction) were incubated with 20 fmol of
32P-labeled 41-mer oligonucleotide in the presence or
absence of the indicated amounts of ATP or ATP S. After incubation at
25 °C for 20 min, formation of MCM-ssDNA complexes were analyzed by
gel mobility shift assay as described under "Materials and
Methods."
|
|
Biochemical Properties of Mcm4/6/7 Helicase Activity--
The
biochemical characteristics of the Mcm4/6/7 DNA helicase activity were
examined (Fig. 5). When increasing levels
of the Mcm4/6/7 complex (glycerol gradient peak fraction) were
incubated with 5 fmol of a helicase substrate DNA (18-mer
oligodeoxynucleotide hybridized to M13 mp18 s DNA) described under
"Materials and Methods," about 60 ng of protein resulted in the
displacement of approximately 40% of the labeled 18-mer oligomer. The
helicase activity associated with the Mcm4/6/7 complex was active
during incubation up to 1 h (Fig. 5A). Therefore, these
conditions were used in the following experiments. As shown in Fig.
5B, DNA helicase activity of the Mcm4/6/7 complex required
ATP or dATP, and ATP hydrolysis was essential for this activity since
the non-nonhydrolyzable ATP analogue, ATP
S, did not support strand
displacement (Fig. 5B). No other rNTPs or dNTPs supported
helicase activity, and the optimal concentration of ATP was about 4 mM under the conditions used.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Properties of the helicase activity of the
Mcm4/6/7 complex. A, influence of the level of Mcm4/6/7
complex and time on the DNA helicase activity. DNA helicase assays were
performed with the indicated amounts of Mcm4/6/7 protein and 5 fmol of
M13 ssDNA/18-mer substrate at 32 °C for 60 min (left
panel). In the right panel, 60 ng of the Mcm4/6/7
protein was incubated with 5 fmol of substrate at 32 °C as
indicated. The numbers at the bottom of the
autoradiogram indicate the % of 18-mer oligonucleotide displaced from
the duplex. B, NTP requirement for DNA helicase activity.
DNA helicase assays were carried out for 60 min at 32 °C with the
indicated amount of Mcm4/6/7 protein and 5 fmol of M13s/18-mer
substrate in the presence or absence of 4 mM rNTPs or
dNTPs. C, the Mcm4/6/7 helicase translocates in the 3' to 5'
direction. Increasing amounts of Mcm4/6/7 protein were incubated with 5 fmol of 3'-tailed substrate or 5'-tailed substrate as described under
"Materials and Methods." Asterisks indicate the position
of the 32P label in the substrate used. Lane B,
boiled substrate; lane 1, no Mcm4/6/7 complex was added;
lanes 2-4 contained 15, 30, or 60 ng of the Mcm4/6/7
complex, respectively; lane 5 contained 60 ng of the
Mcm4/6/7 complex in the absence of ATP.
|
|
In order to determine the direction of translocation of the Mcm4/6/7
helicase on DNA, two different substrates containing either a 3'-ssDNA
tail (substrate A, Fig. 5C) or a 5'-ssDNA tail (substrate B,
Fig. 5C) were prepared as described under "Materials and
Methods." Helicase activity was only observed with the 3'-ssDNA tailed substrate, indicating that the polarity of translocation is in
the 3' to 5' direction.
The processivity of helicase activity was also determined using a
M13mp18 DNA substrate that contained duplex DNA regions that varied
between 22 and 600 base pairs in length. In the presence of 250 ng of
the Mcm4/6/7 complex, the maximum size of the DNA displaced was about
50 base pairs, suggesting that the processivity of this helicase
activity is relatively low (data not shown). We also examined whether
ssDNA-binding proteins influenced the DNA helicase activity. The
addition of S. pombe SSB or E. coli SSB did not
stimulate the helicase activity. The addition of excess amounts of
E. coli SSB markedly inhibited the helicase activity whereas
spSSB did not.
Interaction of Mcm2 or Mcm3/5 with the Mcm4/6/7 Complex--
The
interactions between the isolated Mcm subcomplexes were examined by
immunoprecipitation and glycerol gradient sedimentation analyses.
Various combinations of the purified Mcm preparations were mixed
together and incubated on ice for 8 h. Interactions between these
complexes were analyzed by immunoprecipitations using anti-Mcm4 or
anti-Mcm2 antibodies as described under "Materials and Methods." As
shown in Fig. 6A, the Mcm4/6/7
complex interacted with Mcm2 (lanes 1-3) as well as with
Mcm3/5 (lanes 4 and 5). When all three protein
preparations were incubated together, a complex containing all six
subunits was detected following precipitation with either anti-Mcm4 or
anti-Mcm2 antibodies (lanes 6-8). However, significant
interaction between Mcm2 and the Mcm3/5 complex was not detected
(lanes 9 and 10).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Interactions between various Mcm
subcomplexes. A, the interactions between Mcm
subcomplexes were determined by immunoprecipitation analysis. Various
combinations of Mcm4/6/7 (3 µg), Mcm2 (1 µg), or Mcm3/5 (2 µg)
preparations were mixed as indicated in buffer C (150 µl) containing
0.1 M sodium glutamate and 0.1 mg/µl BSA and incubated on
ice for 8 h. The mixtures were then immunoprecipitated with
polyclonal antibodies against Mcm4 or Mcm2, and the immunoprecipitated
material was analyzed by SDS-PAGE and staining with silver. About 20%
of input material used for immunoprecipitations were loaded in
lanes 1, 4, 6, and 9. B, glycerol
gradient analysis of various Mcm complexes formed from subcomplexes.
The mixtures containing Mcm4/6/7 (3 µg), Mcm2 (1 µg), or Mcm3/5 (2 µg) as indicated were incubated at 25 °C for 20 min and then
loaded onto 5-ml 15-35% glycerol gradients prepared in buffer C plus
0.1 M sodium glutamate. After centrifugation at 45,000 rpm
in a Beckman SW 50.1 rotor at 4 °C for 13 h, 20 fractions were
collected from the bottom, and aliquots (20 µl) were analyzed by
SDS-PAGE and then stained with silver.
|
|
Glycerol gradient sedimentation analyses were also performed to examine
the interactions between these complexes. For this purpose, various
combinations of Mcm4/6/7, Mcm2, or Mcm3/5 complexes were mixed as
indicated and the complexes formed were analyzed by glycerol gradient
centrifugation (Fig. 6B). As shown in Fig. 6B, panel
a, incubation of Mcm4/6/7 with Mcm2 resulted in the formation of a
complex containing Mcm2/4/6/7 subunits that peaked at fractions 10 and
11 after sedimentation. The sedimentation property of this four-subunit
complex was identical to the Mcm2/4/6/7 complex isolated from
Sf9 cells after co-expression of these four subunits (Fig.
1B). This observation suggests that the interaction of Mcm2
with the Mcm4/6/7 complex resulted in the dissociation of the dimeric
structure of Mcm4/6/7 and formation of a monomeric structure of the heterotetramer.
Incubation of Mcm4/6/7 with Mcm3/5 also resulted in the formation of a
complex containing Mcm3/4/5/6/7 subunits (Fig. 6B, panel b).
However, only small amounts of the added Mcm3/5 complex cosedimented
with Mcm4/6/7 in the high molecular weight region (fractions 6 to 9).
Substantial levels of Mcm3/5 and Mcm4/6/7 proteins were detected in the
middle of the gradient, in the vicinity of the catalase marker (232 kDa, 11.3 S). This heterogeneous distribution of Mcm proteins may have
been caused by the dissociation of the Mcm3/4/5/6/7 complex during the
13-h glycerol gradient centrifugation, which yielded Mcm3/5 and
Mcm4/6/7 complexes that sedimented more slowly than the
heteropentameric complex. Although interaction between Mcm4/6/7 and
Mcm3/5 complexes was detected in the immunoprecipitation experiment
(Fig. 6A), the failure to obtain substantial levels of the
five-subunit complex after glycerol gradient sedimentation suggests
that interaction between Mcm4/6/7 and Mcm3/5 is relatively weak. This
notion is in keeping with our failure to purify the Mcm3/4/5/6/7
complex from Sf9 cells. As described above, the Mcm3/4/5/6/7 complex obtained after co-expression and purification using
Ni2+-agarose chromatography, completely dissociated to the
Mcm3/5 and 4/6/7 complex following further purification steps.
The interaction of the Mcm3/5 complex with the Mcm4/6/7 complex
appeared to convert the dimeric Mcm4/6/7 complex to the monomer structure. This conclusion is based on two findings. First, the largest
complex formed containing all five subunits sedimented slower than
thyroglobulin. If Mcm3/5 formed a complex with the dimeric Mcm4/6/7
complex, the size of the dimeric Mcm3/4/5/6/7 complex should be about
924 kDa, which would be expected to sediment faster than thyroglobulin.
As shown (Fig. 6B, panel b), no Mcm proteins sedimenting
faster than thyroglobulin were observed. Second, the presence of
Mcm4/6/7 proteins in the catalase region (panel B, fractions
10-12) also support this suggestion. This Mcm4/6/7 complex, which
appeared to have dissociated from the pentameric Mcm3/4/5/6/7 complex
during glycerol gradient centrifugation, sedimented slower than the
dimeric Mcm4/6/7 complex isolated from Sf9 cells (Fig.
2A). These observations indicated that analogous to Mcm2,
the interaction of Mcm3/5 with Mcm4/6/7 dissociated the dimeric
Mcm4/6/7 complex to a monomeric structure. In the case of Mcm2, the
interaction resulted in the formation of the stable heterotetramer
whereas incubation with Mcm3/5 resulted in the production of the
unstable heteropentamer.
Incubation of Mcm4/6/7 with Mcm2 and Mcm3/5 complex resulted in the
formation of a complex containing all six subunits (Fig. 6B,
panel c, peaking at fractions 7 and 8) that sedimented to the same
position observed with the complex purified from Sf9 cells after
co-expression of all six subunits (Fig. 1A). In accord with
the immunoprecipitation experiment described in Fig. 6A, no
stable interaction between Mcm2 and Mcm3/5 was detected after glycerol
gradient centrifugation analysis (Fig. 6B, panel D). Although Mcm2 alone did not interact with Mcm3/5, the addition of Mcm2
with Mcm4/6/7 and Mcm3/5 complexes yielded a stable six-subunit complex. The interaction of Mcm2 protein with the Mcm4/6/7 complex may
stabilize the interaction between Mcm4/6/7 and Mcm3/5 complexes. These
results suggest that Mcm2 may be important for the formation and
regulation of the six-subunit Mcm complex.
Influence of Mcm2 and Mcm3/5 on the DNA Helicase Activity of the
Mcm4/6/7 Complex--
As described above, only the Mcm4/6/7 complex
contained DNA helicase activity. Because Mcm2 and the Mcm3/5 complex
interacted with the Mcm4/6/7 complex, the influence of these proteins
on the Mcm4/6/7 helicase activity was examined (Fig.
7). For this purpose, the Mcm2, Mcm3/5,
or both protein preparations were added to the standard helicase
reaction mixture containing 60 ng of the Mcm4/6/7 complex in the
absence of the DNA substrate. After incubation at 25 °C for 20 min,
substrate DNA was added and the helicase activity was determined. As
shown in Fig. 7, both Mcm2 and Mcm3/5 inhibited the Mcm4/6/7 helicase
activity. Mcm2 (lanes 3 and 4) was somewhat more
effective as an inhibitor than Mcm3/5 (lanes 5 and
6) and the addition of both proteins (lanes 7 and 8) showed the highest level of inhibition. The inhibitory
effects correlated with the efficiency of interaction between these
complexes. They support the notion that the interaction of the Mcm4/6/7
complex with Mcm3/5 was less stable than the interaction between
Mcm4/6/7 and Mcm2 (described in Fig. 6B). These findings
further support the suggestion that Mcm2 is required to stabilize the
interaction between Mcm4/6/7 and Mcm3/5.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
Influence of Mcm2 and/or Mcm3/5 on the
Mcm4/6/7 helicase activity. Mcm4/6/7, Mcm2, and/or Mcm3/5 proteins
were mixed as indicated in helicase reaction mixtures devoid of the
helicase DNA substrate. After incubation at 25 °C for 20 min, DNA
helicase activity was determined after the addition of 5 fmol of M13
ssDNA/18-mer substrate and further incubation at 32 °C for 60 min.
The lane B indicates that the DNA substrate was boiled. The
percent displacement of the 18-mer from the duplex DNA substrate is
indicated as %.
|
|
 |
DISCUSSION |
The initiation of DNA replication in eukaryotes is a multistep
process that requires a number of proteins. It involves the binding of
ORC to replication origins, the recruitment of Cdc6/Cdc18, the Mcm
complex, and Cdc45 to form the pre-replicative complex, and the
activation of the pre-replicative complex by Cdc7 and Cdc28 protein
kinases to initiate DNA synthesis (6, 11, 51, 52).
In this study, we have reconstituted the S. pombe Mcm
complex containing all six Mcm proteins as well as several subcomplexes with different Mcm subunits using the baculovirus expression system. The coexpression of various combinations of the Mcm proteins yielded several stable complexes including the heterohexameric complex of
Mcm2/3/4/5/6/7 and the subcomplexes Mcm2/4/6/7, Mcm4/6/7, and Mcm3/5.
Although the biological role of these subcomplexes is not fully
understood, the subunit composition of these stable complexes are
consistent with the Mcm complexes previously observed from a number of
immunoprecipitation studies carried out with crude extracts prepared
from several organisms from yeast to human (25, 26, 28, 33, 37, 38).
The direct interaction between purified subcomplexes and the stability
of these interactions observed in this study are consistent with these
earlier observations. They suggest that these interactions are
intrinsic properties of these proteins and not in vitro artifacts.
As described above, only the dimeric form of the Mcm4/6/7 complex
possesses biochemical properties similar to those found with the human
and mouse Mcm4/6/7 complexes (27, 39). None of the other Mcm complexes
contained detectable ATPase, DNA binding, or DNA helicase activities.
Consistent with these results, the interaction of either Mcm2 or Mcm3/5
with the Mcm4/6/7 complex resulted in the loss of DNA helicase activity.
Although all of the Mcm proteins contain conserved ATPase motifs,
significant ATPase activity has been observed only with the Mcm4/6/7
complex. Similar to the observations made with the cloned S. pombe heterohexamer, the S. pombe Mcm2/3/4/5/6/7
complex isolated from asynchronous cultures and from cells synchronized with hydroxyurea at the beginning of S phase were devoid of enzymatic activities (36, 53). Possibly, the motifs responsible for the binding
and hydrolysis of ATP are not exposed in this six-subunit complex. It
is also possible that the activation of the cryptic ATPase activity of
this complex may depend on its interaction with other components of the
pre-replicative complex such as ORC, Cdc6/Cdc18, or Cdc45/Sna1. Studies
carried out with the baculovirus-cloned mouse Mcm4/6/7, in which the
conserved ATPase motifs of either Mcm6 and Mcm4 were mutated, resulted
in the marked loss of DNA helicase and ssDNA binding activity,
respectively (39). Thus, the ATPase motif of each Mcm protein in the
Mcm4/6/7 complex may play distinct roles in the enzymatic activities
associated with the active complex.
The biochemical properties of S. pombe Mcm4/6/7 complex are
comparable to those observed with the human and mouse Mcm4/6/7 complexes with the exception that the ssDNA binding activity of the
S. pombe preparation depended on the presence of ATP or
ATP
S. This difference, however, may be due to the reaction
conditions used. The DNA binding activity of the human and mouse
Mcm4/6/7 complex was examined following cross-linking with
glutaraldehyde. It is possible that weak and/or transient interactions
between the Mcm proteins and DNA in the absence of ATP, which were not observed under our assay conditions even in the nitrocellulose filter
binding assay, may be detected using the cross-linking assay conditions.
The biochemical activities observed with the S. pombe and
human Mcm4/6/7 complexes as well as with the single mthMcm protein are
in keeping with the proposal that the Mcm complex may play a role as a
DNA helicase at replication forks, analogous to that of the E. coli DnaB protein or the SV40 T Ag. This hypothesis is also
consistent with chromatin immunoprecipitation studies that showed
changes in the localization of Mcm proteins (Mcm4 and Mcm7) to
inter-origin regions during S phase (19). However, the limited
processivity of the S. pombe and human Mcm4/6/7 helicase activity (27), suggest that the Mcm proteins may be required only
during the initial step of unwinding of replication origins. It is also
possible that modifications of the Mcm proteins or their interactions
with other replication factors may be required to increase the
processivity of the helicase activity.
The presence of the Mcm proteins in the pre-replicative complex was
demonstrated by chromatin binding experiments in Xenopus and
yeast (17, 54) and in vivo cross-linking of the Mcm proteins to replication origins (19, 20). The Mcm proteins appear to bind
chromatin as a multimeric complex containing all six Mcm proteins (29,
55), which contains no catalytic activities. If the helicase activity
is a critical property of the Mcm complex, as discussed above,
alterations of the six-subunit complex leading to the activation of the
cryptic DNA helicase activity would be required. Possibly, the two S
phase promoting kinases contribute to this alteration by directly
phosphorylating the Mcm proteins. In support of this model, the extent
of phosphorylation of the Mcm proteins has been shown to vary during
the different phases of the cell cycle (18, 56-58) and some of the Mcm
proteins are modified by these two kinases (16, 53, 57, 59, 60). In
S. cerevisiae, a specific mutant allele of
mcm5-bob1 has been shown to suppress all
mutations in CDC7 or DBF4, suggesting that an
alteration in Mcm5 satisfies the essential function of Cdc7-Dbf4 (15).
In addition, a mutant allele of dbf4 has been isolated which
suppresses a mutation in mcm2 (16). These findings suggest that the chief target of the Cdc7-Dbf4 kinase is the Mcm protein complex. Interestingly, Mcm2 appears to be a substrate of the Cdc7-Dbf4
kinase (53, 60). As shown here, Mcm2 appeared to be important for the
formation of a complex containing all six subunits. The interaction
between Mcm4/6/7 and Mcm3/5 was relatively weak, and Mcm2 was required
for the formation of the stable six-subunit complex. Although Mcm2
alone did not interact with Mcm3/5, the binding of Mcm2 to the Mcm4/6/7
complex stabilized the interaction between Mcm4/6/7 and Mcm3/5. This
suggests that the removal of Mcm2 from the hexameric complex or
conformational changes caused by its modifications may lead to the
release of the Mcm4/6/7, which is active as a helicase.
The reconstitution of Mcm complexes reported in this study should
enable us to examine further the role and the regulation of these
proteins in vitro. The modifications of these proteins by
G1-S promoting kinases and the interactions of these
proteins with other replication factors such as ORC, Cdc18, and
Sna41/Cdc45 are currently under investigation.
 |
ACKNOWLEDGEMENT |
We thank Dr. Z.-Q. Pan and Dr. Z. Kelman for
helpful discussions and comments on the manuscript. We are indebted to
B. Phillips for the maintenance and supply of Sf9 cells.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant GM 58559.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Fax: 212-717-3627;
E-mail: j-hurwitz@ski.mskcc.org.
Published, JBC Papers in Press, April 18, 2000, DOI 10.1074/jbc.M001118200
 |
ABBREVIATIONS |
The abbreviations used are:
MCM, minichromosome
maintenance;
ss, single stranded;
ORC, origin recognition complex;
mth, Methanobacterium thermoautotrophicum;
T Ag, simian virus 40 large tumor antigen;
PCR, polymerase chain reaction;
BSA, bovine serum
albumin;
sp, S. pombe;
SSB, single
stranded-binding protein;
Ab, antibody;
PAGE, polyacrylamide gel
electrophoresis;
DTT, dithiothreitol;
ATP
S, adenosine
5'-O-(thiotriphosphate).
 |
REFERENCES |
| 1.
|
Maine, G. T.,
Sinha, P.,
and Tye, B. K.
(1984)
Genetics
106,
365-385
|
| 2.
|
Koonin, E. V.
(1993)
Nucleic Acids Res.
21,
2541-2547
|
| 3.
|
Kearsey, S. E.,
and Labib, K.
(1998)
Biochim. Biophys. Acta
1398,
113-136
|
| 4.
|
Chong, J. P.,
Thommes, P.,
and Blow, J. J.
(1996)
Trends Biochem. Sci.
21,
102-106
|
| 5.
|
Kearsey, S. E.,
Maiorano, D.,
Holmes, E. C.,
and Todorov, I. T.
(1996)
Bioessays
18,
183-190
|
| 6.
|
Tye, B. K.
(1999)
Annu. Rev. Biochem.
68,
649-686
|
| 7.
|
Hennessy, K. M.,
Lee, A.,
Chen, E.,
and Botstein, D.
(1991)
Genes Dev.
5,
958-969
|
| 8.
|
Loo, S.,
Fox, C. A.,
Rine, J.,
Kobayashi, R.,
Stillman, B.,
and Bell, S.
(1995)
Mol. Biol. Cell
6,
741-756
|
| 9.
|
Donovan, S.,
Harwood, J.,
Drury, L. S.,
and Diffley, J. F.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5611-5616
|
| 10.
|
Perkins, G.,
and Diffley, J. F.
(1998)
Mol. Cell
2,
23-32
|
| 11.
|
Dutta, A.,
and Bell, S. P.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
293-332
|
| 12.
|
Hardy, C. F.
(1997)
Gene (Amst.)
187,
239-246
|
| 13.
|
Hopwood, B.,
and Dalton, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12309-12314
|
| 14.
|
Zou, L.,
Mitchell, J.,
and Stillman, B.
(1997)
Mol. Cell. Biol.
17,
553-563
|
| 15.
|
Hardy, C. F.,
Dryga, O.,
Seematter, S.,
Pahl, P. M.,
and Sclafani, R. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3151-3155
|
| 16.
|
Lei, M.,
Kawasaki, Y.,
Young, M. R.,
Kihara, M.,
Sugino, A.,
and Tye, B. K.
(1997)
Genes Dev.
11,
3365-3374
|
| 17.
|
Coleman, T. R.,
Carpenter, P. B.,
and Dunphy, W. G.
(1996)
Cell
87,
53-63
|
| 18.
|
Young, M. R.,
and Tye, B. K.
(1997)
Mol. Biol. Cell
8,
1587-1601
|
| 19.
|
Aparicio, O. M.,
Weinstein, D. M.,
and Bell, S. P.
(1997)
Cell
91,
59-69
|
| 20.
|
Tanaka, T.,
Knapp, D.,
and Nasmyth, K.
(1997)
Cell
90,
649-660
|
| 21.
|
Zou, L.,
and Stillman, B.
(1998)
Science
280,
593-596
|
| 22.
|
Madine, M. A.,
Khoo, C. Y.,
Mills, A. D.,
Mushal, C.,
and Laskey, R. A.
(1995)
Curr. Biol.
5,
1270-1279
|
| 23.
|
Chong, J. P.,
Mahbubani, H. M.,
Khoo, C. Y.,
and Blow, J. J.
(1995)
Nature
375,
418-421
|
| 24.
|
Thommes, P.,
Kubota, Y.,
Takisawa, H.,
and Blow, J. J.
(1997)
EMBO J.
16,
3312-3319
|
| 25.
|
Burkhart, R.,
Schulte, D.,
Hu, D.,
Musahl, C.,
Gohring, F.,
and Knippers, R.
(1995)
Eur. J. Biochem.
228,
431-438
|
| 26.
|
Ishimi, Y.,
Ichinose, S.,
Omori, A.,
Sato, K.,
and Kimura, H.
(1996)
J. Biol. Chem.
271,
24115-24122
|
| 27.
|
Ishimi, Y.
(1997)
J. Biol. Chem.
272,
24508-24513
|
| 28.
|
Kimura, H.,
Ohtomo, T.,
Yamaguchi, M.,
Ishii, A.,
and Sugimoto, K.
(1996)
Genes Cells
1,
977-993
|
| 29.
|
Fujita, M.,
Kiyono, T.,
Hayashi, Y.,
and Ishibashi, M.
(1997)
J. Biol. Chem.
272,
10928-10935
|
| 30.
|
Richter, A.,
and Knippers, R.
(1997)
Eur. J. Biochem.
247,
136-141
|
| 31.
|
Romanowski, P.,
Madine, M. A.,
and Laskey, R. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10189-10194
|
| 32.
|
Kubota, Y.,
Mimura, S.,
Nishimoto, S.,
Masuda, T.,
Nojima, H.,
and Takisawa, H.
(1997)
EMBO J.
16,
3320-3331
|
| 33.
|
Su, T. T.,
Feger, G.,
and O'Farrell, P. H.
(1996)
Mol. Biol. Cell
7,
319-329
|
| 34.
|
Lei, M.,
Kawasaki, Y.,
and Tye, B. K.
(1996)
Mol. Cell. Biol.
16,
5081-5090
|
| 35.
|
Dalton, S.,
and Hopwood, B.
(1997)
Mol. Cell. Biol.
17,
5867-5875
|
| 36.
|
Adachi, Y.,
Usukura, J.,
and Yanagida, M.
(1997)
Genes Cells
2,
467-479
|
| 37.
|
Sherman, D. A.,
Pasion, S. G.,
and Forsburg, S. L.
(1998)
Mol. Biol. Cell
9,
1833-1845
|
| 38.
|
Sherman, D. A.,
and Forsburg, S. L.
(1998)
Nucleic Acids Res.
26,
3955-3960
|
| 39.
|
You, Z.,
Komamura, Y.,
and Ishimi, Y.
(1999)
Mol. Cell. Biol.
19,
8003-8015
|
| 40.
|
Kelman, Z.,
Lee, J. K.,
and Hurwitz, J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14783-14788
|
| 41.
|
Ishimi, Y.,
Komamura, Y.,
You, Z.,
and Kimura, H.
(1998)
J. Biol. Chem.
273,
8369-8375
|
| 42.
|
Baker, T. A.,
and Bell, S. P.
(1998)
Cell
92,
295-305
|
| 43.
|
Leatherwood, J.
(1998)
Curr. Opin. Cell Biol.
10,
742-748
|
| 44.
|
Borowiec, J. A.,
Dean, F. B.,
Bullock, P. A.,
and Hurwitz, J.
(1990)
Cell
60,
181-184
|
| 45.
|
Ishiai, M.,
Sanchez, J. P.,
Amin, A. A.,
Murakami, Y.,
and Hurwitz, J.
(1996)
J. Biol. Chem.
271,
20868-20878
|
| 46.
|
Okishio, N.,
Adachi, Y.,
and Yanagida, M.
(1996)
J. Cell Sci.
109,
319-326
|
| 47.
|
Takahashi, K.,
Yamada, H.,
and Yanagida, M.
(1994)
Mol. Biol. Cell
5,
1145-1158
|
| 48.
|
Maiorano, D.,
Van Assendelft, G. B.,
and Kearsey, S. E.
(1996)
EMBO J.
15,
861-872
|
| 49.
|
McEntee, K.,
Weinstock, G. M.,
and Lehman, I. R.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
857-861
|
| 50.
|
Siegel, L. M.,
and Monty, K. J.
(1966)
Biochim. Biophys. Acta
112,
346-362
|
| 51.
|
Stillman, B.
(1994)
J. Biol. Chem.
269,
7047-7050
|
| 52.
|
Diffley, J. F.
(1996)
Genes Dev.
10,
2819-2830
|
| 53.
|
Brown, G. W.,
and Kelly, T. J.
(1998)
J. Biol. Chem.
273,
22083-22090
|
| 54.
|
Romanowski, P.,
Madine, M. A.,
Rowles, A.,
Blow, J. J.,
and Laskey, R. A.
(1996)
Curr. Biol.
6,
1416-1425
|
| 55.
|
Richter, A.,
Baack, M.,
Holthoff, H. P.,
Ritzi, M.,
and Knippers, R.
(1998)
Biol. Chem.
379,
1181-1187
|
| 56.
|
Fujita, M.,
Yamada, C.,
Tsurumi, T.,
Hanaoka, F.,
Matsuzawa, K.,
and Inagaki, M.
(1998)
J. Biol. Chem.
273,
17095-17101
|
| 57.
|
Hendrickson, M.,
Madine, M.,
Dalton, S.,
and Gautier, J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12223-12228
|
| 58.
|
Coue, M.,
Kearsey, S. E.,
and Mechali, M.
(1996)
EMBO J.
15,
1085-1097
|
| 59.
|
Sato, N.,
Arai, K.,
and Masai, H.
(1997)
EMBO J.
16,
4340-4351
|
| 60.
|
Jiang, W.,
McDonald, D.,
Hope, T. J.,
and Hunter, T.
(1999)
EMBO J.
18,
5703-5713
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Biswas and D. Bastia
Mechanistic Insights into Replication Termination as Revealed by Investigations of the Reb1-Ter3 Complex of Schizosaccharomyces pombe
Mol. Cell. Biol.,
November 15, 2008;
28(22):
6844 - 6857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kanter, I. Bruck, and D. L. Kaplan
Mcm Subunits Can Assemble into Two Different Active Unwinding Complexes
J. Biol. Chem.,
November 7, 2008;
283(45):
31172 - 31182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Bochman, S. P. Bell, and A. Schwacha
Subunit Organization of Mcm2-7 and the Unequal Role of Active Sites in ATP Hydrolysis and Viability
Mol. Cell. Biol.,
October 1, 2008;
28(19):
5865 - 5873.
[Abstract]
[Full Text]
[PDF]
|
 |
|